Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code M33.02

Juvenile dermatomyositis with myopathy is a systemic inflammatory condition affecting muscles and blood vessels in children under 18, characterized by muscle weakness, skin rash, and dysfunction.

Always adhere to the latest ICD-10-CM coding guidelines and conventions provided by the Centers for MedicareMedicaid Services (CMS) and the World Health Organization (WHO).Pay close attention to the inclusion and exclusion notes for M33.02, ensuring that the code accurately reflects the patient's condition and does not overlap with other diagnoses.When using this code, also consider any additional codes needed to fully represent associated complications or comorbidities, if any.

Medical necessity for the diagnosis and treatment of juvenile dermatomyositis with myopathy is established based on the presence of clinical symptoms, such as progressive muscle weakness, characteristic skin rash, and laboratory findings consistent with the diagnosis.Further investigations such as muscle biopsy might be medically necessary to rule out other conditions and confirm the diagnosis.The need for treatment, including corticosteroids and immunosuppressants, is determined based on the severity of the symptoms and the patient's overall clinical condition.

Diagnosis and management of juvenile dermatomyositis with myopathy requires a multidisciplinary approach.Responsibilities include obtaining a thorough patient history, conducting physical examinations, ordering and interpreting laboratory tests (blood tests, muscle enzyme levels, ESR, antinuclear antibodies, etc.), performing imaging studies (MRI), and potentially conducting muscle and skin biopsies.The physician will also determine the appropriate treatment plan, which may include corticosteroids, immunosuppressants, and supportive care.Monitoring the patient's response to treatment and managing any complications are also crucial clinical responsibilities.

IMPORTANT:Other related codes within the M33.x range might be applicable depending on the specific organ involvement (e.g., M33.00 for unspecified organ involvement, M33.01 for respiratory involvement, M33.03 for absence of myopathy).ICD-9-CM codes 359.6 (Symptomatic inflammatory myopathy) and 710.3 (Dermatomyositis) may be used for historical cross-referencing.

In simple words: Juvenile dermatomyositis with myopathy is a condition affecting children where their muscles and skin get inflamed.This causes muscle weakness, making it hard to move or lift things, and a rash. Doctors use tests and sometimes a small tissue sample to confirm the diagnosis. Treatment often involves medication to reduce inflammation and boost the immune system.

Juvenile dermatomyositis with myopathy (M33.02) is a chronic inflammatory disease affecting both muscles (myopathy) and skin. It's a systemic autoimmune disorder primarily affecting children and adolescents under 18 years of age.The condition presents with proximal muscle weakness (difficulty with activities requiring lifting or moving),a characteristic skin rash (heliotrope rash around the eyelids, Gottron papules on the knuckles, and erythema on sun-exposed areas), and sometimes involves other organs.Diagnosis involves clinical evaluation (history, physical examination), laboratory tests (muscle enzyme levels, erythrocyte sedimentation rate (ESR), antinuclear antibodies, specific antibody assays), electromyography (EMG), and muscle and skin biopsies. Treatment typically includes corticosteroids to reduce inflammation and immunosuppressants to manage the autoimmune response.The myopathy component refers to the muscle involvement, leading to the muscle weakness and other symptoms.This specific code (M33.02) highlights the presence of myopathy in the context of juvenile dermatomyositis.

Example 1: A 7-year-old girl presents with progressive muscle weakness, difficulty climbing stairs, and a characteristic purplish rash around her eyelids and on her knuckles.Laboratory tests reveal elevated muscle enzymes and positive antinuclear antibodies.A muscle biopsy confirms the diagnosis of juvenile dermatomyositis with myopathy (M33.02)., A 12-year-old boy experiences muscle pain, stiffness, and fatigue.He also exhibits a heliotrope rash.Further investigation with MRI reveals muscle inflammation and weakness.Blood tests show elevated inflammatory markers. The diagnosis of juvenile dermatomyositis with myopathy is made, and he is started on corticosteroids., A 15-year-old girl has a history of intermittent muscle weakness and a rash that worsens with sun exposure.She develops dysphagia (difficulty swallowing).A multidisciplinary team, including a rheumatologist and a gastroenterologist, conducts a thorough evaluation and diagnoses juvenile dermatomyositis with myopathy. The case requires close monitoring for gastrointestinal complications.

Complete and detailed medical records are essential for accurate coding. This should include a comprehensive history and physical examination, documenting the onset and progression of symptoms, specifically noting muscle weakness, location, and severity.Thorough documentation of skin findings, including rash characteristics, location, and presence of Gottron papules or heliotrope rash, is crucial.Laboratory reports including muscle enzyme levels (CK, aldolase, etc.), ESR, antinuclear antibodies, and other relevant serological markers should be included.Imaging studies such as MRI scans, showing muscle involvement, should also be documented.Finally, pathology reports from any muscle or skin biopsies, confirming the diagnosis, are necessary.

** This code should only be used when the diagnosis of juvenile dermatomyositis with myopathy is confirmed through clinical examination, laboratory testing, and imaging.Always review the patient's medical record carefully to ensure accurate coding.Be aware of the potential for overlap with other musculoskeletal or autoimmune conditions and code accordingly.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.